[1]Shim J, Oh SJ, Yeo E, et al. Integrated analysis of singlecell and spatial transcriptomics in keloids: highlights on fibrovascular interactions in keloid pathogenesis[J]. J Invest Dermatol, 2022, 142(8): 2128-2139.
[2]Liu X, Chen W, Zeng Q, et al. singlecell RNAsequencing reveals lineagespecific regulatory changes of fibroblasts and vascular endothelial cells in keloids[J]. J Invest Dermatol, 2022, 142(1): 124-135.
[3]施晋升, 王茂松, 李本忠, 等. 食管癌细胞来源的外泌体促进人脐静脉血管内皮细胞血管生成[J]. 江苏大学学报(医学版), 2021, 31(5): 412-416, 420.
[4]Dey N, De P, Brian LJ. Evading antiangiogenic therapy: resistance to antiangiogenic therapy in solid tumors[J]. Am J Transl Res, 2015, 7(10): 1675-1698.
[5]Limandjaja GC, Niessen FB, Scheper RJ, et al. Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars[J]. Exp Dermatol, 2021, 30(1): 146-161.
[6]蔡景龙. 瘢痕疙瘩的诊疗指南建议[J]. 中国美容医学, 2016, 25(6): 38-40.
[7]Gastl G, Spizzo G, Obrist P, et al. EpCAM overexpression in breast cancer as a predictor of survival[J]. Lancet, 2000, 356(9246): 1981-1982.
[8]Mankowski P, Kanevsky J, Tomlinson J, et al. Optimizing radiotherapy for keloids: a metaanalysis systematic review comparing recurrence rates between different radiation modalities[J]. Ann Plast Surg, 2017, 78(4): 403-411.
[9]Renz P, Hasan S, Gresswell S, et al. Dose effect in adjuvant radiation therapy for the treatment of resected keloids[J]. Int J Radiat Oncol Biol Phys, 2018, 102(1): 149-154.
[10]Newberry CI, Thomas JR, Cerrati EW. Facial scar improvement procedures[J]. Facial Plast Surg, 2018, 34(5): 448-457.
[11]Limandjaja GC, van den Broek LJ, Waaijman T, et al. Reconstructed human keloid models show heterogeneity within keloid scars[J]. Arch Dermatol Res, 2018, 310(10): 815-826.
[12]Suttho D, Mankhetkorn S, Binda D, et al. 3D modeling of keloid scars in vitro by cell and tissue engineering[J]. Arch Dermatol Res, 2017, 309(1): 55-62.
[13]Limandjaja GC, Belien JM, Scheper RJ, et al. Hypertrophic and keloid scars fail to progress from the CD34 /αsmooth muscle actin (αSMA)+immature scar phenotype and show gradient differences in αSMA and p16 expression[J]. Br J Dermatol, 2020, 182(4): 974-986.
[14]Rask L, Hgdall CK, Kjaer SK, et al. Association of CD31 and p53 with survival of ovarian cancer patients[J]. Anticancer Res, 2019, 39(2): 567-576.
[15]Wimmer I, Tietz S, Nishihara H, et al. PECAM1 stabilizes bloodbrain barrier integrity and favors paracellular TCell diapedesis across the bloodbrain barrier during neuroinflammation[J]. Front Immunol, 2019, 10: 711.
[16]Deng K, Xiao H, Liu X, et al. Strontium90 brachytherapy following intralesional triamcinolone and 5fluorouracil injections for keloid treatment: A randomized controlled trial[J]. PLoS One, 2021, 16(3): e0248799. |